Takeda Faces First Trial Over Actos Diabetes Drug in L.A.Jef Feeley and Margaret Cronin Fisk
Takeda Pharmaceutical Co., Asia’s biggest drugmaker, is facing its first trial of lawsuits alleging that its Actos diabetes drug caused cancer in some patients.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- This $14 Million Atlanta Home With Bunker Is ‘Safest in America’
- Separatists Pledge to Fight On After Spain Moves to Oust Catalan Leaders
- These Cities Make NYC Housing Look Dirt Cheap
- GE's New CEO Vows Sweeping Change After ‘Unacceptable’ Report
- Greenwich Mansion Listings Pulled to Wait for a Better Day